Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew James King currently holds 19,157 shares of CHINOOK THERAPEUTICS, INC. (KDNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew James King has been a net seller of KDNY stock. They have purchased $0 and sold $1.1M worth of shares.
Andrew James King's most recent insider trade was on Aug 11, 2023, when they sold 19,157 shares at $0.00 per share.
Andrew James King serves as Executive at CHINOOK THERAPEUTICS, INC. (KDNY). They have executed 28 insider transactions totaling $1.1M over their tenure at the company.
Andrew James King holds the position of Executive at CHINOOK THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Andrew James King has shown a selling trading pattern, with $0 in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew James King was on Jan 3, 2023, when they sold $258.2K worth of KDNY shares. This transaction involved 10,000 shares at $25.82 per share.
Andrew James King currently owns 19,157 shares of CHINOOK THERAPEUTICS, INC. (KDNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew James King's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew James King has 28 Form 4 filings on record as an insider at CHINOOK THERAPEUTICS, INC..
Set alerts for Andrew James King and 40,000+ other insiders.